Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US

IMPORTANCE: Updated estimates of non-small cell lung cancer (NSCLC) in the US are needed. A smaller proportion of patients aged 65 years or older with stage IV NSCLC were treated.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 OBJECTIVE: To calculate the most recent epidemiologic estimates of NSCLC in the US.
• 2 DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional epidemiological analysis used the most recently released data from US cancer registries.
• 3 The population-based US Cancer Statistics (USCS) database (2010-2017), comprised of the Surveillance, Epidemiology, and End Results (SEER) program and the National Program of Cancer Registries (NPCR) (collectively, SEER-NPCR) provided the NSCLC incidence estimate.

This work deepens our understanding of the fundamental laws governing the universe, from subatomic particles to cosmic structures.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: